Skip to main content
. 2021 Oct 6;9(28):8327–8339. doi: 10.12998/wjcc.v9.i28.8327

Figure 2.

Figure 2

Effect of conventional and alternative drugs in diabetic patients with coronavirus disease 2019. SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; ACE: Angiotensin converting enzyme; ARB: Angiotensin II receptor blocker; TZD: Thiazolidinediones; GLP-1: Glucagon-like peptide 1; DPP4: Dipeptidyl peptidase 4; hrsACE2: Human recombinant soluble angiotensin converting enzyme 2.